UNSPSC 51372307: Loperamide oxide

This classification denotes an opioid and antidiarrheal agent with the molecular formula C29H33ClN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6X9OC3H4II, chemically known as 4-(4-chlorophenyl)-n,n-dimethyl-alpha,alpha-diphenyl-4-hydroxy-1-piperidinebutanamide but generally known as loperamide, which bears US NIH Compound Identifier 3955. European Medicines Agency schedules Loperamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08572MIG.

UNSPSC 51372307 Loperamide oxide is a Commodity code that nominally designates a specific pharmaceutical ingredient, but recent state and local solicitations under this code tag procurement of opioid antagonists and drug deactivation systems rather than loperamide itself. State and local governments are using this code to buy naloxone (an opioid overdose reversal medication) and associated drug disposal or neutralization equipment, reflecting a mismatch between the code's technical pharmaceutical scope and the harm-reduction and public health products actually being solicited. Issuing bodies under this code include county health departments and community health programs pursuing competitive bidding to support opioid crisis response and community health initiatives.

Seminole County, Florida posted an IFB (Solicitation Number IFB60459723LAS) on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The response deadline was July 26, 2023, at 2:00 pm, with bids submitted electronically through the county's e-Procurement Portal. Vendors must include all shipping and delivery costs in their proposals, maintain drug-free workplace certification and E-Verify compliance, and carry workers' compensation, commercial general liability, and professional liability insurance. The contract structure includes an initial two-year term with a one-year renewal option and a three-month probationary period allowing Seminole County to terminate with or without cause. The procurement noted potential FEMA funding and associated federal compliance requirements. Limited recent activity appears under this code; the Seminole County opportunity represents a concrete signal of county-level demand for overdose-response products, though the mismatch between the code designation and actual procurement scope suggests this code may not be the primary descriptor for similar health-department acquisitions statewide.